TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).

Alan L Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.